How much does Mounjaro cost without insurance?

How much is Mounjaro without insurance?

Quick answer: About $1,103.95 to $1,112.16 per 28-day fill of four pens, at any dose (as of October 8, 2026). GoodRx shows coupons from $1,087.18, location not shown.

Mounjaro comes as a box of four single-dose pens, one per week, and Lilly defines a fill as 28 days. Unlike Zepbound, the price does not change with the dose: Lilly’s list price, Costco’s member price and GoodRx’s per-dose coupons are all flat across 2.5 to 15 mg.

Without a published self-pay program, the cash price of Mounjaro stays near its list price, which is the starting point for what a pharmacy charges without insurance; $1,112.16 is Lilly’s figure, read on Lilly pricing information: Mounjaro.

Can I buy Mounjaro self-pay from LillyDirect like Zepbound?

Quick answer: Not at a published price. LillyDirect’s Mounjaro page showed no self-pay price on October 8, 2026; Lilly says only that self-pay savings options may exist.

Lilly’s pricing page for Mounjaro says that if your insurance does not cover it, or you have none, “you may be eligible for self-pay savings options,” without giving a figure. Its LillyDirect page for Mounjaro listed no self-pay price when we checked. Zepbound, by contrast, has a full self-pay price list — see how much Zepbound costs without insurance.

Can I use the Mounjaro savings card without insurance?

Quick answer: No. Both Mounjaro cards require commercial insurance: as little as $25 if your plan covers it, $499 if it doesn’t. Government coverage is excluded.

Lilly’s Mounjaro savings page, checked on the date above, sets these terms:

• Plan covers Mounjaro: pay as little as $25 for a 1-, 2- or 3-month fill. Savings are capped at $150 per 1-month fill and $1,950 a year, up to 13 fills.
• Commercial plan does not cover Mounjaro: pay as low as $499 for a 28-day fill of up to four pens, with savings capped at $647 a month.
• No insurance, or Medicare / Medicaid: neither card applies.

Both cards expire December 31, 2026. A side-by-side of every brand’s card is in Mounjaro, Zepbound and Wegovy savings cards explained.

What is the $499 Mounjaro price on TrumpRx?

Quick answer: A listing marked “eligibility required” that TrumpRx doesn’t explain. Lilly’s only published Mounjaro price at that figure is its card for commercial plans that don’t cover Mounjaro.

TrumpRx.gov lists Mounjaro at $499 at every strength, next to an original price that matches Lilly’s list price, and links to Lilly. The listing says eligibility is required but does not say who is eligible. Until Lilly or TrumpRx publishes that rule, treat $499 as the commercial-insurance card price, not as a price for people without insurance. Source: TrumpRx.gov, read from the page data on October 8, 2026.

Why does Zepbound cost less than Mounjaro without insurance?

Quick answer: Lilly sells Zepbound self-pay from $299 a month but publishes no self-pay price for Mounjaro. They are separate products with different approved uses.

Both are Lilly brands of tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for its own uses, including chronic weight management. A prescriber chooses the product for your diagnosis — one is not a stand-in for the other, and a cash price alone shouldn’t decide it.

What differs is how Lilly sells them. Zepbound has a LillyDirect self-pay list ($299–$699 a month by dose, as of October 8, 2026); Mounjaro does not.

What if I have Medicare or Medicaid?

Quick answer: Lilly’s Mounjaro cards exclude government coverage. Ask your Part D or Medicaid plan about coverage, and about CMS’s GLP-1 Bridge ($50 copay) if you’re eligible.

Coverage for Mounjaro depends on your plan’s formulary, your diagnosis and any prior authorization. CMS’s Medicare GLP-1 Bridge, which runs from July 1, 2026, to December 31, 2027, gives eligible Part D members a $50 copay for certain GLP-1 drugs; CMS does not list which on its page. Source: CMS: Medicare GLP-1 Bridge.

Is there a compounded option?

Quick answer: Yes. REMEVi offers compounded tirzepatide, prescribed by licensed providers: From $225 per 4 weeks on the 24-week plan · or $269 every 4 weeks, cancel any time.

A compounded medication is prepared by a state-licensed pharmacy for one patient’s prescription. Compounded medication is not FDA-approved and is not a generic of Mounjaro. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Brand names appear on this page only to orient you; REMEVi does not sell brand-name drugs.

At REMEVi, a licensed provider reviews your health questionnaire and decides whether a prescription is appropriate. Compounded tirzepatide: From $225 per 4 weeks on the 24-week plan · or $269 every 4 weeks, cancel any time. Each plan has one price at every dose and every renewal of that plan, with no membership fee, and you get a full refund if you are not prescribed.

To weigh it against other programs, read our dated comparison of GLP-1 telehealth programs; every REMEVi plan and term is on the pricing page.